[November 16, 2016] |
|
PAREXEL International to Participate in Evercore ISI MedTools Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it
will be attending the Evercore ISI (News - Alert) MedTools Conference in Boston. Josef
von Rickenbach, Chairman and Chief Executive Officer, will participate
on Wednesday, November 30, 2016.
About PAREXEL International PAREXEL International
Corporation is a leading global biopharmaceutical services company,
providing a broad range of expertise-based clinical research,
consulting, medical communications, and technology solutions and
services to the worldwide pharmaceutical, biotechnology and medical
device industries. Committed to providing solutions that expedite
time-to-maret and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to clinical
pharmacology, clinical trials management, and reimbursement. PAREXEL
Informatics (News - Alert) provides advanced technology solutions, including medical
imaging, to facilitate the clinical development process. Headquartered
near Boston, Massachusetts, PAREXEL has offices in 85 locations in 51
countries around the world, and had approximately 18,750 employees in
the first quarter. For more information about PAREXEL International
visit www.PAREXEL.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161116005233/en/
[ Back To TMCnet.com's Homepage ]
|